HEALTH AND RETIREMENT STUDIES
AROUND THE WORLD
This project fosters a cross-country research agenda by encouraging the development of new health and retirement studies around the world and their harmonization with existing studies that are comparable to the Health and Retirement Studies (HRS), and facilitating further innovations among this network of surveys. Click here to learn more about the studies.
Principal Investigator:
David Weir, PhD (U Michigan), Principal Investigator
Rose M Li, MBA, PhD (RLA), Project Manager
NOTICES
The Gateway to Global Aging Data and Social Science and Medicine invite submissions for a conference and special issue dedicated to interdisciplinary research studying how education influences health and ageing globally. Submissions of extended abstracts are due March 31, 2025, and the conference will take place in Boston, Massachusetts from September 4-5, 2025. Please review the detailed call for submissions for more information.
During the October 2024 Council, the NIA approved the concept “Institutional Research Training Award for AD/ADRD And Aging Research in Low – and Middle-Income Countries (LMICs)”. You can read more about this approved concepts, as well as others on the NIA Approved Concepts webpage.
The National Institute on Aging (NIA) has introduced two new funding opportunities. The first, PAR-25-213, invite applications for implementation research that aims to improve the availability of effective, equitable, efficient, integrated, patient-centered, safe, and timely care for people living with multiple long-term conditions (non-communicable disease (NCD) multimorbidity) in low- and middle-income countries (LMICs) and/or within American Indian/Alaska Native (AI/AN) populations in the United States. The application deadline for this program is are Friday, February 7, 2025, and Wednesday, November 5, 2025. The second opportunity, RFA-AG-25-031 is a Small Research Grant Program aimed at emerging researchers from low – and middle-income countries (LMICs) focusing on aging and Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD). Clinical trials are not permitted under this grant, with applications due by Friday, February 14, 2025.
Contact Us